After Pfizer launched yet another takeover bid for AstraZeneca (LSE: AZN) (NYSE: AZN.US) and the latter turned it down once more, Jill Ralph and Nate Weisshaar take a closer look at the UK-based pharmaceutical company in this investing video, and ask what Astra shareholders should be doing now…
https://youtu.be/uyHwiRVZ0Hk